Business
Viemed Healthcare Announces Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today ...
About this update from Viemed Healthcare, Inc.
[{"type":"text","content":"LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and six months ended June 30, 2025.","length":361,"tagName":"p"},{"type":"text","content":"Operational highlights (all dollar amounts are USD; comparisons are to the period ended June 30, 2024 unless otherwise noted):","length":126,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenues for the quarter ended June 30, 2025 were $63.1 million, setting another Company record, representing an increase of $8.1 million, or 14.7%, over net revenues reported for the comparable quarter ended June 30, 2024.","length":227,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":227,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to Viemed for the quarter ended June 30, 2025 totaled $3.2 million, or $0.08per diluted share, an increase of 115.1% over net income attributable to Viemed of $1.5 million, or $0.04 per diluted share, for the quarter ended June 30, 2024.","length":261,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":261,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA for the quarter ended June 30, 2025 totaled $14.3 million, an 11.5% increase as compared to the quarter ended June 30, 2024. A reconciliation of reported non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures can be found in the tables accompanying this press release.","length":320,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":320,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"During the second quarter of 2025, the Company repurchased and cancelled 270,061 common shares under its share repurchase program at a cost of $1.8 million, representing an average buyback price of $6.79 per share.","length":214,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":214,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"The Company increased its ventilator patient count to 12,152 as of June 30, 2025, an increase of ...